BPH Medication for Enlarged Prostate in Busan, Korea — Alpha-Blocker, 5-ARI, PDE5i | From $50/mo | Urogyn
BPH Medication Therapy

BPH medication in Busan, Seomyeon

Five evidence-based drug classes. Tier 1 treatment before considering procedures. 60–70% of patients see significant IPSS improvement on properly selected medication. Dr. Moon Hyeon-chang manages thousands of BPH cases annually at our Busan Seomyeon clinic from $50/month.

From
$50/mo
Drug classes
5
Effect
1–2 wks
Consultation
English
WhatsApp Dr. Moon → See drug classes
Dr. Moon Hyeon-chang — BPH medication specialist at Urogyn Busan Seomyeon
Dr. Moon Hyeon-chang Board-Certified Urologist · 15+ Years · BPH Specialist
The 30-second summary
Read time: 7 min
Drug classes
5
Alpha, 5-ARI, Combo, PDE5i, Phyto
First-line
Alpha-blocker
1–2 week effect
Pricing
$50-120/mo
Drug + follow-up
Success rate
60-70%
Significant IPSS drop
Meet Dr. Moon

A message from Dr. Moon on BPH medication in Seomyeon, Busan.

Before considering BPH procedures (Progator, Rezum, TURP), most patients should try medication first. Learn from Dr. Moon Hyeon-chang which of the 5 drug classes fits your IPSS profile and prostate volume. 15+ years of BPH experience, all explained in clear English.

Dr. Moon personally manages every BPH case at our Busan Seomyeon practice. About 70% of patients can be managed with medication alone for years before procedures become necessary. Starting with the wrong drug class wastes months — proper IPSS assessment and prostate volume measurement guide the right choice from the start.

AUA Member EAU Member 15+ Years 4,000+ BPH Patients
💊
Clinical Consultation Image
[ Insert photo of Dr. Moon during BPH medication consultation ]
Five drug classes

The 5 BPH medications, compared honestly.

Choice depends on IPSS score, prostate volume, sexual function priority, and comorbidities. Wrong drug class means wasted months. Right choice can keep you procedure-free for decades.

Tier 1 · First-line

Alpha-blockers

Tamsulosin (Flomax), Silodosin (Rapaflo), Alfuzosin (Uroxatral)

Onset
1–2 weeks
Cost
$50–70/month
Prostate effect
No shrinkage
Best for
Symptom relief

Mechanism

Relaxes prostate smooth muscle, improving urinary flow immediately. Does not shrink prostate. Most common first-line choice for moderate symptoms (IPSS 8–19).

Best for Patients needing fast symptom relief, prostate under 40g, moderate IPSS (8–19). Most common first prescription. Side effects: retrograde ejaculation (10–30% with Tamsulosin/Silodosin), dizziness, nasal congestion.
Tier 1 · Long-term

5-Alpha Reductase Inhibitors (5-ARI)

Finasteride (Proscar), Dutasteride (Avodart)

Onset
3–6 months
Cost
$60–80/month
Prostate effect
20–30% shrinkage
Best for
Large prostates

Mechanism

Blocks conversion of testosterone to DHT, gradually shrinking prostate by 20–30% over 6+ months. Long-term disease modification, not immediate symptom relief.

Best for Prostate volume over 40g, slow progression preference, willing to wait 3–6 months for effect. Side effects: decreased libido (5–10%), ED (3–5%), decreased ejaculate volume, rare gynecomastia. Lowers PSA by ~50% (factor in for cancer screening).
Tier 2 · Combination

Combination Therapy

Tamsulosin + Dutasteride (Combodart, Jalyn) or separate prescriptions

Onset
1–2 wks + 6mo
Cost
$80–120/month
Prostate effect
Shrinkage + relax
Best for
Moderate-severe BPH

Mechanism

Immediate alpha-blocker symptom relief + long-term 5-ARI prostate shrinkage. Most effective regimen for moderate-severe BPH with large prostate. CombAT study showed 67% risk reduction for progression.

Best for IPSS 15+ with prostate volume over 40g, high progression risk patients, those wanting to maximize medical therapy before procedures. Side effect profile combines both classes.
Tier 2 · BPH + ED

PDE5 Inhibitors Daily

Tadalafil 5mg daily (Cialis daily)

Onset
2–4 weeks
Cost
$70–90/month
Prostate effect
Smooth muscle relax
Best for
BPH + ED combined

Mechanism

FDA-approved for both BPH and ED. Improves urinary symptoms and erectile function simultaneously. No retrograde ejaculation. Excellent for sexually active patients with mild-moderate BPH and any degree of ED.

Best for Patients with both BPH and ED, IPSS 8–19, prioritizing sexual function preservation, those who developed retrograde ejaculation on Tamsulosin. Side effects: headache, flushing, back pain. Contraindicated with nitrates.
Tier 3 · Adjunct

Phytotherapy

Saw Palmetto (Serenoa repens), Pygeum africanum, Beta-sitosterol

Onset
4–8 weeks
Cost
$20–40/month
Prostate effect
Mild/uncertain
Best for
Mild cases, preference

Mechanism

Anti-inflammatory and weak 5-ARI-like effects. Evidence mixed in clinical trials — some patients report subjective benefit, but objective measures show modest improvement at best.

Best for Mild BPH (IPSS under 8), patients preferring natural options, adjunct to other medications. Not recommended as sole therapy for moderate-severe BPH. Generally well-tolerated.
Diagnosis pathway

How we select your medication at the first visit.

Drug choice is based on objective measurements. IPSS score alone is insufficient — prostate volume, uroflowmetry, and patient priorities together guide the right prescription.

1

IPSS questionnaire

~10 min · Day 1

International Prostate Symptom Score quantifies urinary symptoms (0–35) and QoL impact. Determines severity and tracks treatment response. Required at every visit.

2

Uroflowmetry

~15 min · same day

Objective measurement of urinary flow rate (Qmax). Qmax under 10 mL/sec indicates significant obstruction. Helps differentiate BPH from bladder dysfunction.

3

Prostate ultrasound

~10 min

Transrectal or transabdominal ultrasound measures prostate volume. Volume over 40g favors 5-ARI inclusion. Also checks for post-void residual urine (PVR).

4

PSA + urine analysis

~5 min · 48hr result

PSA rules out prostate cancer concern (note: 5-ARI cuts PSA in half). Urine analysis rules out infection. Baseline labs guide medication choice.

Severity scoring

Understanding your IPSS score.

The standardized BPH severity measurement. Score 0–35 across 7 urinary symptom questions plus quality-of-life impact. Determines treatment intensity and tracks response.

What your IPSS score means

IPSS is administered at every visit to objectively track treatment response. A 3-point reduction is clinically meaningful. Most patients on combination therapy achieve 5–10 point reductions over 3–6 months.

0–7
Mild
Watchful waiting or phytotherapy. Lifestyle changes (reduce evening fluids, double voiding) often sufficient. No urgent need for prescription medication.
8–19
Moderate
Medication recommended. Alpha-blocker first-line. Add 5-ARI if prostate >40g. Consider PDE5i daily if ED is also present.
20–35
Severe
Combination therapy from start. Reassess at 3 months. If no improvement or complications develop, procedure evaluation (Progator, Rezum, TURP) recommended.
When medication isn't enough

Escalation to procedures : when and why.

About 70% of BPH patients remain on medication long-term. The other 30% eventually need procedures. Knowing when to escalate prevents prolonged suffering.

Indication 1

Failed combination therapy

IPSS remains over 20 despite alpha-blocker + 5-ARI for 6 months. Quality of life severely impacted. Patient ready for procedure to avoid lifelong medication.

→ Discuss Progator , Rezum , or TURP
Indication 2

Acute urinary retention

Sudden inability to urinate, requiring catheterization. Indicates significant obstruction. Recurrence rate over 50% on medication alone. Procedure typically recommended.

→ Urgent evaluation, usually TURP or Rezum
Indication 3

Bothersome side effects

Persistent retrograde ejaculation (Tamsulosin), libido loss (5-ARI), or daily medication burden. Patient prefers one-time procedure over indefinite drugs.

→ Progator preserves sexual function
Indication 4

Complications develop

Recurrent UTIs, bladder stones, kidney function impairment, or significant post-void residual (over 200mL). Medication cannot reverse anatomical issues.

→ Procedure evaluation prioritized
Indication 5

Very large prostate

Prostate volume over 80g. Medical therapy less effective at this size. Some procedures (Rezum, TURP) work better than others (Progator limited).

→ Rezum or TURP usually recommended
Indication 6

Patient preference

Some patients prefer definitive procedure to lifelong medication, especially if planning international travel or simplifying daily regimen.

→ Discuss all BPH options with Dr. Moon
Common questions

What men ask about BPH medication in Busan.

BPH medication therapy in Busan starts from $50/month for alpha-blockers (Tamsulosin). 5-ARI: $60–80/month. Combination therapy: $80–120/month. PDE5i daily: $70–90/month. Phytotherapy: $20–40/month.

Initial consultation $74 includes IPSS workup, uroflowmetry, prostate ultrasound, and PSA. Korean medication pricing is 60–80% lower than US private equivalents.

Alpha-blockers(Tamsulosin, Silodosin) — fast urinary symptom relief, no prostate shrinkage.

5-ARI(Finasteride, Dutasteride) — shrinks prostate 20–30% over 6+ months.

Combination therapy — both classes together for moderate-severe BPH.

PDE5i daily(Tadalafil 5mg) — for BPH + ED combined.

Phytotherapy(Saw Palmetto) — mild cases or patient preference.

Alpha-blockers: symptoms improve in 1–2 weeks. 5-ARI: 6+ months for full prostate shrinkage effect. Combination: immediate alpha-blocker effect plus 5-ARI long-term benefit at 6 months.

Most patients see significant improvement within first 2 months. If no improvement at 3 months, dose adjustment, drug switch, or procedure consideration is appropriate.

Consider procedures (Progator, Rezum, TURP) when: (1) IPSS remains over 20 despite combination therapy for 6 months, (2) acute urinary retention requiring catheterization, (3) recurrent UTIs, (4) bladder stones develop, (5) kidney function impacted by obstruction, (6) bothersome side effects from medication, (7) patient prefers definitive procedure.

About 25–30% of BPH patients eventually need a procedure. The other 70% remain well-controlled on medication for years to decades.

Initial assessment requires in-person visit: IPSS questionnaire, uroflowmetry, prostate volume by ultrasound, PSA, urine analysis. These cannot be done remotely.

After initial diagnosis and medication start, ongoing management can largely be conducted via WhatsApp — Dr. Moon adjusts doses, switches medications, monitors side effects, and refills prescriptions remotely. Annual in-person follow-up recommended for objective measurements.

Alpha-blockers: retrograde ejaculation (10–30% with Tamsulosin/Silodosin), dizziness on standing, nasal congestion, occasional fatigue.

5-ARI: decreased libido (5–10%), ED (3–5%), decreased ejaculate volume, rare gynecomastia. Lowers PSA by ~50% (factor in for cancer screening interpretation).

PDE5i daily: headache, flushing, back pain. Contraindicated with nitrates.

Most side effects are mild. Switching to a different drug within the same class (e.g., Silodosin to Alfuzosin) often resolves persistent issues.

Alpha-blockers can be stopped relatively quickly without rebound — symptoms simply return to baseline within days. Some patients try "drug holidays" for travel.

5-ARI should not be abruptly stopped — prostate gradually regrows over 12+ months. Stopping during combination therapy means prostate begins regrowing.

Generally, BPH is a chronic condition requiring lifelong management. Symptoms return when medication stops because the underlying cause (prostate enlargement) persists.

Yes — 5-ARI (Finasteride, Dutasteride) lowers PSA by approximately 50% after 6+ months of treatment. This must be factored in for prostate cancer screening.

Practical approach: multiply measured PSA by 2 to get the "true" PSA equivalent. If on 5-ARI, a PSA of 2.0 ng/mL effectively means 4.0 ng/mL. Dr. Moon tracks PSA trends carefully on these medications.

Evidence-based lifestyle modifications: (1) Reduce evening fluid intake after 6pm, (2) Limit caffeine and alcohol (both diuretics), (3) Avoid decongestants (worsen retention), (4) Double voiding (urinate, wait 30 seconds, urinate again), (5) Pelvic floor exercises, (6) Maintain healthy weight (obesity worsens BPH), (7) Regular exercise (associated with reduced BPH progression).

Lifestyle alone is appropriate for mild BPH (IPSS under 8). For moderate-severe, lifestyle complements but doesn't replace medication.

Three reasons: (1) Korean medication pricing is 60–80% lower than US private equivalents — annual savings of $1,000–$3,000 for combination therapy patients. (2) Dr. Moon's 4,000+ BPH patient experience means proper drug selection from the start, avoiding wasted months on wrong class. (3) Ongoing WhatsApp management after initial visit avoids repeated international trips while maintaining specialist-level care.

International patients often combine medication initiation with 2–3 day Busan tourism, then continue remote management for years.

Related conditions

Related procedures at our Busan Seomyeon clinic.

P

Prostate Care Hub

Complete overview of BPH treatment options. Compare medication, minimally invasive procedures, and surgery at our Busan clinic.

Read more
G

Progator Procedure

Minimally invasive ligation when medication isn't enough. Preserves sexual function. 20–40 minute outpatient procedure from $3,000.

Read more
E

Erectile Dysfunction

PDE5i daily (Tadalafil 5mg) treats both BPH and ED simultaneously. Frequently used combination therapy at our Busan clinic.

Read more
Your next step

Find the right BPH medication for your case.

Free WhatsApp consultation with Dr. Moon. Share your current symptoms, IPSS score (if known), and any previous medications tried. Receive personalized drug class recommendation before booking your visit to Busan.

5
Drug classes
15+
Years experience
4,000+
BPH patients
60-80%
Less than US/UK
WhatsApp Dr. Moon → Back to home